Medrol and prednisone are not the same medication, but they are closely related. Both are synthetic corticosteroids used to reduce inflammation, and they treat many of the same conditions. The key differences come down to potency, how the body processes each drug, and cost.
How the Two Drugs Differ
Medrol is the brand name for methylprednisolone. Prednisone is a separate corticosteroid. Both belong to the intermediate-acting class of glucocorticoids, meaning they work on a similar timeline in the body. But they are chemically distinct, and that distinction matters in a few practical ways.
Prednisone is a prodrug, which means it isn’t active on its own. After you swallow it, your liver converts it into its active form (prednisolone) using a specific enzyme called 11β-HSD1. Methylprednisolone skips that step entirely. It’s already active when it enters your bloodstream. For most people this difference is irrelevant, but for someone with significant liver disease, methylprednisolone can be the better choice because it doesn’t depend on liver function to work.
Potency and Dose Equivalence
Methylprednisolone is about 25% more potent than prednisone, milligram for milligram. The standard equivalence is 4 mg of methylprednisolone to 5 mg of prednisone. So if you’re switching from one to the other, the doses won’t be identical. Your prescriber will adjust accordingly.
Methylprednisolone also has a slightly higher anti-inflammatory rating. On a relative potency scale where hydrocortisone equals 1, prednisone scores a 4 and methylprednisolone scores a 5. In practical terms, this means you typically take a slightly lower milligram dose of Medrol to get the same anti-inflammatory effect.
How Long Each One Lasts
Both drugs are classified as intermediate-acting corticosteroids, but methylprednisolone stays in the bloodstream a bit longer. Prednisone has a plasma half-life of about 60 minutes, while methylprednisolone ranges from about 78 to 188 minutes. This doesn’t necessarily mean you’ll feel effects longer with one versus the other, since how long a corticosteroid suppresses inflammation (its biological half-life) extends well beyond its time in the blood. But the difference can influence how often each drug is dosed in certain treatment plans.
Effectiveness for the Same Conditions
For most inflammatory and autoimmune conditions, the two drugs perform similarly. A randomized trial in patients with polymyalgia rheumatica (an inflammatory condition causing muscle pain and stiffness) compared a daily dose of 25 mg prednisone to 20 mg methylprednisolone. Both groups saw comparable drops in inflammation markers, and both suppressed the body’s stress hormone axis to a similar degree. However, full remission came faster with methylprednisolone: an average of 15.2 days compared to 20.3 days with prednisone. Overall remission rates were also slightly higher, with 100% of the methylprednisolone group achieving remission compared to 89% on prednisone.
That said, this was a small preliminary study, and for the vast majority of prescriptions, doctors consider the two drugs interchangeable at equivalent doses. Both are used for asthma flares, COPD exacerbations, autoimmune diseases, allergic reactions, organ transplant rejection, inflammatory bowel disease, certain blood disorders, and many other conditions.
Side Effects and Salt Retention
Corticosteroids can cause fluid retention, weight gain, elevated blood sugar, mood changes, insomnia, and bone thinning with long-term use. These side effects overlap heavily between prednisone and methylprednisolone, but there’s one notable difference: methylprednisolone causes less sodium retention than prednisone. Sodium retention leads to water retention, bloating, and can raise blood pressure. For people with heart failure or hypertension, this distinction sometimes tips the choice toward methylprednisolone.
Both drugs can increase potassium loss, and both carry the same long-term risks (bone density loss, increased infection risk, adrenal suppression) when used for extended periods at higher doses.
Cost Difference
This is where the two drugs diverge sharply. Generic prednisone is one of the cheapest prescription medications available. A supply of 100 tablets of prednisone 20 mg runs roughly $14 to $17 without insurance. The same quantity of Medrol (methylprednisolone 2 mg tablets) costs around $168 without insurance. Even in generic form, methylprednisolone tends to be significantly more expensive than prednisone. If both drugs would work equally well for your condition, prednisone is the far more affordable option.
When One Is Chosen Over the Other
Most of the time, the choice between these two drugs comes down to physician preference, cost, and patient-specific factors rather than a clear clinical advantage of one over the other. Situations where methylprednisolone might be preferred include liver disease (since it doesn’t need hepatic activation), conditions where minimizing fluid retention matters, or cases where a slightly faster onset of remission is desirable. Prednisone is more commonly prescribed overall, largely because of its low cost and long track record.
If you’ve been prescribed one and are wondering whether you could switch to the other, the answer is usually yes, with a dose adjustment. At equivalent doses, they produce very similar clinical results.